Overview

Patient Satisfaction After Switching to Oral Testosterone Undecanoate

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate patient satisfaction with an oral testosterone agent, Jatenzo, compared to other forms of testosterone therapy.
Phase:
Phase 4
Details
Lead Sponsor:
University of Miami
Collaborator:
Clarus Therapeutics
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate